Table of Contents

company-logo

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

Vaxcyte Dividend Announcement

• Vaxcyte does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Vaxcyte dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Vaxcyte Dividend History

Vaxcyte Dividend Yield

Vaxcyte current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Vaxcyte stock? Use our calculator to estimate your expected dividend yield:

Vaxcyte Financial Ratios

P/E ratio-22.43
PEG ratio0.35
P/B ratio3.33
ROE-23.53%
Payout ratio0.00%
Current ratio17.88
Quick ratio17.88
Cash Ratio8.48

Vaxcyte Dividend FAQ

Does Vaxcyte stock pay dividends?
Vaxcyte does not currently pay dividends to its shareholders.
Has Vaxcyte ever paid a dividend?
No, Vaxcyte has no a history of paying dividends to its shareholders. Vaxcyte is not known for its dividend payments.
Why doesn't Vaxcyte pay dividends?
There are several potential reasons why Vaxcyte would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Vaxcyte ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Vaxcyte has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Vaxcyte a dividend aristocrat?
Vaxcyte is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Vaxcyte a dividend king?
Vaxcyte is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Vaxcyte a dividend stock?
No, Vaxcyte is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Vaxcyte stocks?
To buy Vaxcyte you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Vaxcyte stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.